Cabinet rules that South Africans must be given antiretrovirals

Meanwhile, the Global Fund to Fight AIDS, Malaria, and Tuberculosis has announced that a grant it has been waiting to give to organisations in South Africa has finally been signed. The stumbling block, although officially attributed to bureaucratic problems, has been that the programme included the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 2003-08, Vol.327 (7411), p.357-357
1. Verfasser: Sidley, Pat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 357
container_issue 7411
container_start_page 357
container_title BMJ
container_volume 327
creator Sidley, Pat
description Meanwhile, the Global Fund to Fight AIDS, Malaria, and Tuberculosis has announced that a grant it has been waiting to give to organisations in South Africa has finally been signed. The stumbling block, although officially attributed to bureaucratic problems, has been that the programme included the use of antiretrovirals. A sum of $27m (L17m; euro24m) will go to a two year programme in KwaZulu-Natal, the province said to be hardest hit by the epidemic, with a sero-prevalence of 36%.
doi_str_mv 10.1136/bmj.327.7411.357
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1126780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25455255</jstor_id><sourcerecordid>25455255</sourcerecordid><originalsourceid>FETCH-LOGICAL-b543t-8e8b6427f76b71e85d18963477588b6c793f67f06d2da6bf16f37703a82d02fd3</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxS0Eoquldy6gCCQuKIu_x7mA2ggoaAUHoOJmOYnT9bJJiu2s6H9fR1ktBQlxmsP7zZs3egg9JnhFCJOvqm67YhRWwAlZMQH30IJwqXKhGLuPFrgQRa4IUyfoNIQtxpgyUIUUD9EJoQUpCsAL9KY0lettzPy4syGLGxOzL8MYN9lZ611t-pB1Y4hZZbMrt7d9ZvrovI1-2DtvduERetCmYU8Pc4m-vXv7tbzI15_ffyjP1nklOIu5sqqSnEILsgJilWhIisI4gFBJqaFgrYQWy4Y2RlYtkS0DwMwo2mDaNmyJXs--12PV2aa2fUzn9bV3nfE3ejBO_6n0bqOvhr0mhEpQOBm8OBj44edoQ9SdC7Xd7UxvhzFoYELAdHKJnv0FbofR9-k5TTHHnBElEvT8XxBJLpJwrmSi8EzVfgjB2_aYl2A9dahThzp1qKcOdeowrTy9--fvhUNjCXgyA9sQB3_UqeBCUDEly2fdhWh_HXXjf2gJDIT-dFnq7-p8fV5-vNST38uZn6L8N94tbXa8ig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777614486</pqid></control><display><type>article</type><title>Cabinet rules that South Africans must be given antiretrovirals</title><source>MEDLINE</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Jstor Complete Legacy</source><source>Alma/SFX Local Collection</source><creator>Sidley, Pat</creator><creatorcontrib>Sidley, Pat</creatorcontrib><description>Meanwhile, the Global Fund to Fight AIDS, Malaria, and Tuberculosis has announced that a grant it has been waiting to give to organisations in South Africa has finally been signed. The stumbling block, although officially attributed to bureaucratic problems, has been that the programme included the use of antiretrovirals. A sum of $27m (L17m; euro24m) will go to a two year programme in KwaZulu-Natal, the province said to be hardest hit by the epidemic, with a sero-prevalence of 36%.</description><edition>International edition</edition><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 0959-8146</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.327.7411.357</identifier><identifier>PMID: 12919970</identifier><identifier>CODEN: BMJOAE</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Anti-HIV Agents - supply &amp; distribution ; Antiretroviral Therapy, Highly Active - economics ; Cabinet ; Drugs ; Financing, Government ; HIV ; HIV Infections - drug therapy ; HIV Infections - economics ; Human immunodeficiency virus ; Humans ; Legislation, Drug ; News ; South Africa</subject><ispartof>BMJ, 2003-08, Vol.327 (7411), p.357-357</ispartof><rights>2003 BMJ Publishing Group Ltd.</rights><rights>Copyright 2003 BMJ Publishing Group Ltd</rights><rights>Copyright: 2003 (c) 2003 BMJ Publishing Group Ltd.</rights><rights>Copyright BMJ Publishing Group Aug 16, 2003</rights><rights>Copyright © 2003, BMJ Publishing Group Ltd. 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b543t-8e8b6427f76b71e85d18963477588b6c793f67f06d2da6bf16f37703a82d02fd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/25455255$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/25455255$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,27903,27904,30978,57995,58228</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12919970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sidley, Pat</creatorcontrib><title>Cabinet rules that South Africans must be given antiretrovirals</title><title>BMJ</title><addtitle>BMJ</addtitle><description>Meanwhile, the Global Fund to Fight AIDS, Malaria, and Tuberculosis has announced that a grant it has been waiting to give to organisations in South Africa has finally been signed. The stumbling block, although officially attributed to bureaucratic problems, has been that the programme included the use of antiretrovirals. A sum of $27m (L17m; euro24m) will go to a two year programme in KwaZulu-Natal, the province said to be hardest hit by the epidemic, with a sero-prevalence of 36%.</description><subject>Anti-HIV Agents - supply &amp; distribution</subject><subject>Antiretroviral Therapy, Highly Active - economics</subject><subject>Cabinet</subject><subject>Drugs</subject><subject>Financing, Government</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - economics</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Legislation, Drug</subject><subject>News</subject><subject>South Africa</subject><issn>0959-8138</issn><issn>0959-8146</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkc1v1DAQxS0Eoquldy6gCCQuKIu_x7mA2ggoaAUHoOJmOYnT9bJJiu2s6H9fR1ktBQlxmsP7zZs3egg9JnhFCJOvqm67YhRWwAlZMQH30IJwqXKhGLuPFrgQRa4IUyfoNIQtxpgyUIUUD9EJoQUpCsAL9KY0lettzPy4syGLGxOzL8MYN9lZ611t-pB1Y4hZZbMrt7d9ZvrovI1-2DtvduERetCmYU8Pc4m-vXv7tbzI15_ffyjP1nklOIu5sqqSnEILsgJilWhIisI4gFBJqaFgrYQWy4Y2RlYtkS0DwMwo2mDaNmyJXs--12PV2aa2fUzn9bV3nfE3ejBO_6n0bqOvhr0mhEpQOBm8OBj44edoQ9SdC7Xd7UxvhzFoYELAdHKJnv0FbofR9-k5TTHHnBElEvT8XxBJLpJwrmSi8EzVfgjB2_aYl2A9dahThzp1qKcOdeowrTy9--fvhUNjCXgyA9sQB3_UqeBCUDEly2fdhWh_HXXjf2gJDIT-dFnq7-p8fV5-vNST38uZn6L8N94tbXa8ig</recordid><startdate>20030816</startdate><enddate>20030816</enddate><creator>Sidley, Pat</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QJ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20030816</creationdate><title>Cabinet rules that South Africans must be given antiretrovirals</title><author>Sidley, Pat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b543t-8e8b6427f76b71e85d18963477588b6c793f67f06d2da6bf16f37703a82d02fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anti-HIV Agents - supply &amp; distribution</topic><topic>Antiretroviral Therapy, Highly Active - economics</topic><topic>Cabinet</topic><topic>Drugs</topic><topic>Financing, Government</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - economics</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Legislation, Drug</topic><topic>News</topic><topic>South Africa</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sidley, Pat</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sidley, Pat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cabinet rules that South Africans must be given antiretrovirals</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>2003-08-16</date><risdate>2003</risdate><volume>327</volume><issue>7411</issue><spage>357</spage><epage>357</epage><pages>357-357</pages><issn>0959-8138</issn><issn>0959-8146</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><coden>BMJOAE</coden><abstract>Meanwhile, the Global Fund to Fight AIDS, Malaria, and Tuberculosis has announced that a grant it has been waiting to give to organisations in South Africa has finally been signed. The stumbling block, although officially attributed to bureaucratic problems, has been that the programme included the use of antiretrovirals. A sum of $27m (L17m; euro24m) will go to a two year programme in KwaZulu-Natal, the province said to be hardest hit by the epidemic, with a sero-prevalence of 36%.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>12919970</pmid><doi>10.1136/bmj.327.7411.357</doi><tpages>1</tpages><edition>International edition</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ, 2003-08, Vol.327 (7411), p.357-357
issn 0959-8138
0959-8146
1468-5833
1756-1833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1126780
source MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Jstor Complete Legacy; Alma/SFX Local Collection
subjects Anti-HIV Agents - supply & distribution
Antiretroviral Therapy, Highly Active - economics
Cabinet
Drugs
Financing, Government
HIV
HIV Infections - drug therapy
HIV Infections - economics
Human immunodeficiency virus
Humans
Legislation, Drug
News
South Africa
title Cabinet rules that South Africans must be given antiretrovirals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A57%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cabinet%20rules%20that%20South%20Africans%20must%20be%20given%20antiretrovirals&rft.jtitle=BMJ&rft.au=Sidley,%20Pat&rft.date=2003-08-16&rft.volume=327&rft.issue=7411&rft.spage=357&rft.epage=357&rft.pages=357-357&rft.issn=0959-8138&rft.eissn=1468-5833&rft.coden=BMJOAE&rft_id=info:doi/10.1136/bmj.327.7411.357&rft_dat=%3Cjstor_pubme%3E25455255%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777614486&rft_id=info:pmid/12919970&rft_jstor_id=25455255&rfr_iscdi=true